A number of factors such as the favorable reimbursement environment and government support in selected countries; advantages of insulin pens over syringes and vials; technological advancements to minimize pain and needle anxiety; growing diabetic population; and conferences, meetings, and congresses to create pen needle awareness are expected to drive the growth of the pen needles market during the forecast period.

http://www.marketsandmarkets.com/Market-Reports/pen-needles-market-75948613.html

Early buyers will receive 10% customization on reports.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=75948613

Geographically, the global pen needles market is divided into North America, Europe, Asia, and the Rest of the World (Latin America, Pacific countries, the Middle East, and Africa). Europe is expected to account for the largest share of the pen needles market in 2016, followed by North America, Asia, and the Rest of the World. The Asian market is projected to grow at the highest CAGR and serves as a revenue pocket for companies offering pen needle products

Prominent players in the global pen needles market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Owen Mumford, Ltd. (U.K.), HTL-STREFA S.A. (Poland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), and Artsana S.p.a. (Italy).

In this report, the pen needles market is segmented on the basis of type, needle length, therapy, mode of purchase, and region. Based on type, the pen needles market is categorized into standard pen needles and safety pen needles. The standard pen needles segment is expected to account for the largest share of the pen needles market in 2016. However, the safety pen needles segment is projected to grow at a higher CAGR during the forecast period.